INIS
adults
7%
antibodies
8%
antigens
8%
applications
10%
asia
8%
assessments
9%
attitudes
8%
biological markers
6%
blood
11%
cancer
39%
children
22%
chromatin
9%
comparative evaluations
21%
concentration
8%
control
23%
coronaviruses
9%
cost
7%
covid-19
17%
cytokines
6%
data
40%
death
13%
design
8%
detection
8%
diabetes mellitus
10%
diseases
77%
distribution
8%
dna
6%
doses
8%
drugs
16%
epidemiology
11%
evaluation
7%
females
10%
genes
29%
genetics
12%
glucose
7%
growth factors
5%
guidelines
7%
healing
8%
hepatitis
11%
heterochromatin
22%
histones
10%
hiv
23%
hospitals
17%
humans
30%
in vitro
10%
in vivo
6%
income
6%
inflammation
16%
information
6%
injuries
9%
interactions
8%
interventions
11%
kazakhstan
53%
kidneys
25%
learning
6%
levels
32%
liver
10%
losses
11%
males
9%
management
22%
men
6%
mice
16%
molecules
6%
mortality
23%
mutations
7%
nervous system diseases
5%
ovaries
7%
pain
15%
pakistan
9%
pathogenesis
5%
patients
100%
pediatrics
13%
people
9%
populations
31%
pregnancy
11%
proteins
43%
quality of life
6%
rats
7%
receptors
9%
regeneration
6%
regulations
6%
reviews
44%
risks
37%
saudi arabia
8%
screening
9%
sex
6%
stem cells
13%
surgery
22%
surveys
7%
therapy
18%
tissues
18%
tuberculosis
6%
tumors
14%
units
6%
universities
9%
vaccines
10%
values
13%
viruses
15%
women
30%
wounds
9%
Medicine and Dentistry
Chronic Kidney Disease
9%
Cohort Effect
7%
COVID-19
8%
Cross Sectional Study
5%
Diagnosis
7%
Disease
12%
Endometriosis
6%
Global Disease Burden
8%
Human Immunodeficiency Virus
8%
Infection
6%
Malignant Neoplasm
10%
Meta-Analysis
7%
Mortality Rate
6%
Neoplasm
5%
Pediatrics
9%
Prevalence
17%
Systematic Review
7%
Keyphrases
Celiac Disease
6%
Central Asia
6%
COVID-19
7%
Heterochromatin
7%
Heterochromatin Proteins
8%
Human Immunodeficiency Virus Type 1 (HIV-1)
7%
Kazakhstan
25%
Pakistan
6%
Risk Factors
5%